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Upconversion Cross-Correlation Spectroscopy of a Sandwich
Immunoassay
Satu Lahtinen+,[a] Stefan Krause+,[b] Riikka Arppe,[b] Tero Soukka,*[a] and Tom Vosch*[b]
Abstract: Fluorescence correlation and cross-correlation
spectroscopy (FCS/FCCS) have enabled biologists to study
processes of transport, binding, and enzymatic reactions
in living cells. However, applying FCS and FCCS to samples
such as whole blood and plasma is complicated as the
fluorescence bursts of diffusing labels can be swamped by
strong autofluorescence. Here we present cross-correla-
tion spectroscopy based on two upconversion nanoparti-
cles emitting at different wavelengths on the anti-Stokes
side of a single excitation laser. This upconversion cross-
correlation spectroscopy (UCCS) approach allows us to
completely remove all Stokes shifted autofluorescence
background in biological material such as plasma. As a
proof of concept, we evaluate the applicability of UCCS to
a homogeneous sandwich immunoassay for thyroid stimu-
lating hormone measured in buffer solution and in
plasma.
Throughout the past fifty years, fluorescence (cross-)correlation
spectroscopy (FCS/FCCS) has been established as an important
tool in life sciences.[1] It enabled numerous in vitro and in vivo
studies of membrane diffusion, enzymatic activities, protein–
protein interactions and others.[2] Since FCS/FCCS is based on
measuring fluorescence fluctuations in a diffraction-limited
volume of a few femtoliters, it allows detecting dye concentra-
tions down to the single molecule level (usually sub-nanomo-
lar).
However, when it comes to strong autofluorescent samples,
for example, blood or plasma, the FCS/FCCS signal of sub-
nanomolar probe concentrations might vanish in the spectrally
overlapping autofluorescence background. In addition, con-
ventional FCS and FCCS labels, such as fluorescent dyes and
proteins, are also vulnerable to photobleaching and fluores-
cence intermittency, which can disturb the FCS/FCCS signal.[3]
Here we present a correlation spectroscopy method based on
upconversion emission of lanthanide-doped nanoparticles.[4]
Upconversion nanoparticles (UCNPs) have the ability to convert
low energy near-infrared (NIR) light into emission at ultraviolet
or visible wavelengths due to a sequential absorption of two
or more photons.[4b] Because the Stokes-shifted autofluores-
cence occurs at NIR wavelengths, detecting the anti-Stokes
shifted upconverted emission allows us to easily remove the
entire autofluorescence background. Moreover, UCNPs exhibit
excellent photostability, lanthanide ion-specific narrow band
emission and low cytotoxicity.[5] A minor drawback accompany-
ing UCNP application is the low quantum yield which, howev-
er, can be compensated by higher excitation power and tailor-
ing of the particle size which affects both, brightness and aver-
age diffusion time through the laser focus.[6]
We demonstrate the potential of our approach by applying
upconversion cross-correlation spectroscopy (UCCS) to an im-
munoassay for thyroid stimulating hormone (TSH). The assay is
based on anti-TSH antibody-conjugated green (NaYF4 :Yb
3+ ,
Er3+) and blue (NaYF4 :Yb
3+ ,Tm3+)-emitting UCNPs measured at
spectrally separated detection channels. Thereby, the cross-cor-
relation amplitude of the two channels serves as an indicator
for the formation of the sandwich complex between the two
nanoparticles and the analyte.
The NaYF4 :Yb
3+ ,Tm3+ and NaYF4 :Yb
3+ ,Er3+ UCNPs used in
the study were 30 nm and 26 nm in average dimension, re-
spectively, according to TEM images (Figure S1, Supporting In-
formation). The principle of the UCCS TSH sandwich immuno-
assay is illustrated in Scheme 1. The TSH is bound by the blue
emitting NaYF4 :Yb
3+ ,Tm3+ and the green emitting NaYF4 :Yb
3+ ,
Er3+ UCNPs which are conjugated with antibodies recognizing
different epitopes of TSH, thus forming a sandwich complex.
The immunoassay is a separation-free homogeneous assay and
therefore no washing steps are needed. During the UCCS mea-
surement the binding of the TSH analyte is recognized from
the simultaneous emission of blue and green light upon
977 nm laser excitation. The unbound single particles only
emit at their specific wavelength being recognized in either
the Er3+ (green) or Tm3+ (blue) detection channel.
We measured photon macro times (elapsed time since the
start of the measurement) to construct intensity time traces by
binning the detected photons in time intervals of 2 ms as can
be seen in Figure 1a for the mixture of NaYF4 :Yb
3+ ,Tm3+ and
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NaYF4 :Yb
3+ ,Er3+ antibody conjugated UCNPs in buffer without
TSH analyte.[7] It is obvious from Figure 1a and the cross-corre-
lation amplitude ACC in Figure 1b that the two detection chan-
nels for Er3+ and Tm3+ do not show any simultaneous fluores-
cence bursts. Adding 2880 mIUL@1 of the TSH analyte to the
UCNP mixture in buffer results in binding of the NaYF4 :Yb
3+ ,
Tm3+ and NaYF4 :Yb
3+ ,Er3+ particles to the analyte and in fluo-
rescence bursts being detected simultaneously in both chan-
nels as shown in Figure 1c, for example, at around 210 s and
290 s. This can also be seen from the increased ACC in Fig-
ure 1d versus b. An observed issue in the UCCS-based sand-
wich immunoassay was the formation of large UCNP aggre-
gates. These aggregates can emerge either from UCNP-aggre-
gation without TSH being involved (due to non-specific inter-
actions between the UCNPs) or from TSH induced bridging of
more than two UCNPs (specific binding). In order to try and
remedy this issue, large intensity bursts above 100 counts per
2 ms were removed from the dataset before auto- (AC) and
cross-correlation (CC) functions were calculated by applying a
multiple-tau algorithm with progressive binning.[7] An example
of such large intensity spikes in the dataset and their effect on
the CC function can be seen in Figure S2 in the Supporting In-
formation. For analysis of the binding events between the
antibody-conjugated NaYF4 :Yb
3+ ,Tm3+ and NaYF4 :Yb
3+ ,Er3+
UCNPs, we are most of all interested in ACC. This amplitude was
extracted by fitting a stretched exponential with the correla-
tion time tS and the stretching exponent b in Equation (1) to
the data.
A tð Þ ¼ ACC ? expð@t=tSÞb þ 1 ð1Þ
Application of a stretched exponential function mainly takes
into account dimer/multimer formation and size polydispersity
of the UCNPs. We like to mention that in standard FCS/FCCS
applications based on dye molecules, a three-dimensional dif-
fusion model is more appropriate.[8] However, in the present
case we are not facing diffusion of a chemically well-defined
molecule but rather diffusion of polydisperse nano-particles
with a probability of forming aggregates. Figure 1b and d dis-
play examples of AC and CC functions for the mixtures with 0
and 2880 mIUL@1 TSH analyte. Examination of the CC function
(red) reveals amplitudes of 0.043 (0 mlUL@1 TSH) and 2.66
(2880 mlUL@1 TSH). The increased ACC results from binding of
the antibody conjugated Er3+ and Tm3+ doped UCNPs by the
TSH analyte which then diffuse as a sandwich complex
through the laser focus and emit simultaneously in both detec-
tion channels. From this we can conclude that ACC depends
strongly on the TSH concentration. On the other hand, the
auto-correlation amplitudes AAC remain at least similar as ex-
pected for a constant concentration of both UCNP species
(final concentration 0.0118 mgmL@1 in measurement volume
for NaYF4 :Yb
3+ ,Tm3+ and NaYF4 :Yb
3+ ,Er3+ . See also Figure S3
in the Supporting Information). The variations in AAC for
NaYF4 :Yb
3+ ,Er3+ and NaYF4 :Yb
3+ ,Tm3+ in Figure 1b and d can
be explained by statistical fluctuations for this short example
trace. However, averaging over about five to ten, 300 s long in-
tensity traces for a distinct concentration yields similar AAC
values (see Figure S3). We like to point out that deviations in
the simultaneous emission of the two linked UCNPs could
occur due to differences in the rates of their inherent excita-
tion energy-migration dynamics and relatively long apparent
luminescent lifetimes in the range of a few hundred microsec-
onds.[9] This could be problematic if the diffusion times for
passing the diffraction limited spot were on the same time-
scale of the luminescence decay time. From theoretical calcula-
tions we expect a diffusion time of 15.4 ms (see calculations in
Figure S4). In order to compare this value to our experimental
data we have to apply the above mentioned three-dimensional
diffusion model.[8] However, the previously described particle
polydispersity and aggregation prevents us to simply apply a
one-component three-dimensional diffusion model but re-
quires at least two components as can be seen from the fitting
residuals in Figure S5. We attribute the first and faster diffusion
component to the desired translational diffusion of either
Scheme 1. Principle of the UCCS TSH sandwich immunoassay. The bound
TSH is recognized by the simultaneous diffusion of NaYF4 :Yb
3+ ,Tm3+ (blue)
and NaYF4 :Yb
3+ ,Er3+ (green) nanoparticles through the 977 nm laser focal
volume resulting in coincident emission of both species.
Figure 1. a) Example of a time trace for a mixture of NaYF4:Yb3+ ,Er3+
(green) and NaYF4:Yb3+ ,Tm3+ (blue) antibody-conjugated UCNPs without
TSH. The traces were binned to 2 ms. b) AC and CC curves calculated from
the data in a). c) Example of a time trace of a similar mixture of UCNPs as
presented in a) containing 2880 mIUL@1 TSH. The traces were binned to
2 ms. d) AC and CC curves calculated from the data in c).
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single UCNPs or sandwich complexes consisting of only two
UCNPs bound by a TSH analyte. This first component yields an
average value of 13.5 ms (from the AC fitting) in good agree-
ment with the theoretical value for the diffusion of single
UCNPs and 27 ms (from the CC fitting) for the diffusion of the
TSH bound sandwich structure (see Figure S6). The second and
slower diffusion component is associated with larger aggre-
gates being formed. The contribution of the second amplitude
to the overall AAC and ACC is limited, as can be seen from com-
paring Figure 2 with Figure S6.
A standard curve for the UCCS TSH sandwich immunoassay
calculated from ACC is shown in Figure 2. ACC increases when
both NaYF4 :Yb
3+ ,Tm3+ and NaYF4 :Yb
3+ ,Er3+ UCNPs are bound
to TSH simultaneously. Figure 2 shows a clear dependency of
the ACC versus TSH concentration with a linear increase be-
tween 28.8–2880 mIUL@1 of TSH in the double logarithmic
plot. The limit of detection (LoD) was calculated by adding
three times the standard deviation to the average ACC of the
blank (0 mIUL@1 TSH) sample. The standard curve was fitted
with a four-parameter logistic function of the form ACC=A1+
(A1@A2)/(1+ (cTSH/c0)p) with fitting parameters A1=0.07:0.02,
A2=2.77:0.3, c0= (12:8)V103 mIUL@1 and p=0.56:0.08.[10]
The LoD for TSH in the binding reaction was 15 mIUL@1
(14 mIUL@1 for the fast component of the two-component
three-dimensional diffusion model as shown in Figure S6). For
the UCCS measurements, the actual reaction mixture was dilut-
ed 33 times. The undiluted values were used to create the
standard curve in Figure 2. The normal range of TSH in serum
is 0.3–5.0 mIUL@1 and thus, the LoD for our proof of principle
sandwich immunoassay reaction is not able to detect normal
TSH values in human serum.[11] However, there is significant
room for improvement in the sandwich immunoassay by opti-
mizing the surface chemistry of the UCNPs in order to prevent
aggregation. Additionally, the presented proof of concept was
a separation-free homogeneous assay with a short incubation
time of 30 min and thus, cannot be compared to the highly
sensitive heterogeneous assays with longer incubation times
and washing of extra reagents reaching LoD values down to
60V10@6 mIUL@1.[12]
The major issue limiting the LoD is the UCNP aggregation.
The nanoparticles can aggregate during the surface modifica-
tion steps and they can bind non-specifically with each other
during the immunoassay. The high luminescence bursts of ag-
gregates influence the CC function and cause strong variations
of the amplitudes even after obviously too high bursts are re-
moved.[13] Therefore, the monodispersity of the UCNPs is of
high importance but challenging to achieve with any nanopar-
ticles.[14] The LoD could also be lowered by optimizing the
UCNP concentration. In the current immunoassay, the molar
amount of the individual UCNPs was estimated to be two
times higher than the highest TSH concentration tested. The
UCNP conjugates were intended to have more than one anti-
body attached but the exact number of antibodies per UCNP
was not determined. The nanoparticle concentration has to be
larger than the concentration of the analyte in order to reduce
bridging of multiple nanoparticles (cross-linking, multimer for-
mation). These high nanoparticle concentrations increase their
non-specific aggregation probability and reduce the AAC and
ACC (Figure S7, Supporting Information). By optimizing the
nanoparticle concentration for lower TSH values the LoD could
be improved. In addition, increasing the measurement time
from five minutes per trace to longer times would also im-
prove statistics and therefore sensitivity. However, the UCNPs
had a tendency to stick to the glass coverslip over time and
hence effectively lower the concentration of UCNPs and linked
UCNPs over time. This could be prevented by coating the glass
coverslips with bovine serum albumin (BSA), or by using an
uncleaned coverslip where the droplet would have a smaller
contact area with the glass surface.
Despite the aforementioned issues that still require optimi-
zation, the UCCS sandwich immunoassay was tested with
normal human plasma and plasma spiked with 28.8 mIUL@1 of
TSH (Figure 3). In the spiked plasma the NaYF4 :Yb
3+ ,Tm3+ and
NaYF4 :Yb
3+ ,Er3+ UCNPs have highly correlated time traces and
large ACC values (see open triangle in Figure 2), but even in the
normal plasma (with a low intrinsic concentration of THS; see
open circle in Figure 2) the ACC value reached a similar magni-
tude within the accuracy of our measurement. This can be ex-
plained with the increased non-specific binding and aggrega-
tion of UCNPs in plasma due its complex composition. The
lack of autofluorescence in the UCCS measurements was dem-
onstrated by recording emission spectra of UCNPs in the pres-
ence of plasma when excited at 977 nm and 458 nm (used for
common fluorescence labels), see Figure 3c. The 458 nm exci-
tation exhibits strong autofluorescence, which would swamp
the fluorescence of all standard FCS/FCCS labels at sub-nano-
molar concentrations. With 977 nm NIR excitation no autofluor-
escence was detected on the anti-Stokes side of the excitation.
Figure 2. Standard curve for the TSH immunoassay. The curve was fitted
with a four-parameter logistic function. The dashed lines represent the limit
of detection of the curve. The open circle and open triangle represent ACC
values for measurements in normal unspiked (plotted at 0 mIUL@1) and
spiked (plotted at 28.8 mIUL@1) plasma. The intrinsic amount of TSH in the
plasma was not determined and hence not added to the spiked and un-
spiked amount plotted in the graph. The amplitudes ACC were extracted by
fitting a stretched exponential function to the experimental data. The ACC
values and their error bars represent the averaged amplitudes and standard
deviations of at least five replicate measurements with a length of 300 s
each.
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The latter experiment shows the large potential of UCCS, since
it gives no background in the native plasma sample.
In this study, UCCS was presented and its applicability was
evaluated using a homogeneous TSH sandwich immunoassay.
In the assay, simultaneous emission of two differently emitting
UCNPs was detected upon sandwich formation with the TSH
analyte. Upconversion emission detection enabled measure-
ments completely free from autofluorescence in buffer and in
plasma, but the detectability of TSH in plasma was degraded
by the aggregation of UCNPs. The study, however, demon-
strates the use of the UCNP labels for UCCS and the great po-
tential of UCCS for samples and environments challenging for
conventional FCCS measurements. In addition, our work on
UCCS constitutes a proof of concept which is not restricted to
in vitro immunoassays, but has potential also to in vivo appli-
cations, for example, in cells. Improvements in particle surface
chemistry to prevent aggregation and non-specific interactions




3+ ,Er3+ (XYb=0.17, XEr=0.03) and NaYF4 :Yb
3+ ,
Tm3+ (XYb=0.2, XTm=0.005) UCNPs were synthesized in organic
oils.[15] Poly(acrylic acid) (PAA, M=2000 gmol@1, Sigma–Aldrich)
was used for UCNP coating. Monoclonal antibody (Mab) clones
5404 and 5409 specific for human TSH were purchased from Medix
Biochemica (Espoo, Finland). Human TSH was from Scripp Labora-
tories (San Diego, CA). N-hydroxysuccinimide (sulfo-NHS) and N-(3-
dimethylaminopropyl)-N’-ethylcarbodiimide (EDC) were from
Sigma–Aldrich (St. Louis, MO). Bovine serum albumin (BSA) was
purchased from Bioreba. Assay buffer was from Kaivogen (Kaivo-
gen Assay Buffer, Turku Finland).
Upconverting nanoparticle surface chemistry. After the synthesis,
the oleic acid-covered UCNPs are insoluble in water and do not
have any functional groups. Therefore, after removing the oleic
acid the NaYF4 :Yb
3+ ,Er3+ and NaYF4 :Yb
3+ ,Tm3+ UCNPs were
coated with PAA.[16] After the PAA coating, the green-emitting
NaYF4 :Yb
3+ ,Er3+ UCNPs were conjugated to Mab-5409 antibody
and the blue-emitting NaYF4 :Yb
3+ ,Tm3+ UCNPs to Mab-5404. The
Mab 5404 and Mab 5409 recognize two different epitopes on
human TSH and therefore, enable simultaneous binding of green
and blue emitting UCNPs to the same TSH molecule. The Mab con-
jugation to UCNPs was performed according to protocol described
previously using standard EDC/sulfo-NHS chemistry.[17] In the reac-
tion, 0.167 mg of Mab was used for 2 mg of UCNPs in a 250 mL
volume.
Immunoassay. The final volume of the TSH immunoassay was
30 mL comprising the combined volume of 17.8 mL of NaYF4 :Yb
3+ ,
Er3+ and NaYF4 :Yb
3+ ,Tm3+ Mab conjugated UCNPs in assay buffer
in final concentrations of 0.39 mgmL@1 and 10 mL TSH in tris-saline-
azide buffer (TSA) supplemented with 75 gL@1 BSA (further referred
to as TSA-BSA) in final concentrations of 0–2880 mIU·L@1. The activ-
ity of TSH was 10.8 IUmg@1 as provided from the manufacturer.
The total volume of the sample was adjusted to 30 ml with assay
buffer. The final TSA-BSA amount in the sample was 20%, the re-
maining 80% was assay buffer. The antibodies were enabled to
bind with TSH for 30 minutes and then a 33-fold dilution was
made to assay buffer/D2O (1/10) for the UCCS, giving final UCNP
concentration of 0.0118 mgmL@1 in the measurement volume. The
dilution contained 10% of assay buffer to prevent aggregation
after diluting the nanoparticles. Otherwise the UCNPs were diluted
to D2O to enhance the lanthanide emission intensity and prevent
sample heating due to water absorption by the laser.[18]
A plasma pool collected from healthy volunteers was spiked with
TSH so that the final concentrations of plasma and added TSH in
the reaction were 20% and 28.8 mIU·L@1, respectively. Also non-
spiked plasma was used. The spiked plasma was added in 10 ml
volume to the mixture of NaYF4 :Yb
3+ ,Er3+ and NaYF4 :Yb
3+ ,Tm3+
Mab conjugated UCNPs in assay buffer, and the volume was ad-
justed to 30 ml with assay buffer. The immune complex was al-
lowed to form for 30 minutes before diluting as mentioned above.
Upconversion Cross-Correlation Spectroscopy. UCCS time traces
were acquired with a home-build confocal microscope.[19] The
setup is shown in Figure S8 in the Supporting Information along
with all optical components. We used the output of a continuous
wave Ti-sapphire laser (3900S Spectra-Physics) which was tuned to
an emission wavelength of 977 nm. The laser emission was cleaned
up by a 815 nm long pass filter (HQ815LP) and then reflected by a
30:70 beam splitter (XF122 Omega Optical) into an oil immersion
objective (Olympus, UPlanSApo 100V NA=1.4) focusing the laser
on a spot with a 1/e2—beam radius of about 840 nm (see Fig-
ure S4). The fluorescence signal was collected with the same objec-
tive. The laser light was blocked by a 950 nm short pass filter (Sem-
rock FF01-950/SP-25) and a 700 nm short pass filter (Chroma,
ET700SP-2P8). The upconversion signal was separated into two
spectral channels for detection of the emission of either the
erbium or thulium doped UCNPs only by a 488 nm dichroic mirror.
Further spectral filtering was achieved with a band pass filter (RPB
520–560) and a long pass filter (BLP01-532R-25) in the erbium
channel and a band pass filter (FF01-473/10–25 at 548 angle of in-
Figure 3. a) Example time trace of a plasma sample spiked with 28.8 mIUL@1
of TSH for Er3+ (green detection channel) and Tm3+ (blue detection chan-
nel). The traces were binned to 2 ms. The spiked plasma sample was pre-
pared the same way as the standard TSH-dilutions, except by using a
plasma pool collected from healthy volunteers in place of TSA-BSA. The final
plasma and TSH concentrations in the reaction were 20% and 28.8 mIUL@1,
respectively. The intrinsic amount of TSH in the plasma was not determined
and not included in the TSH concentration. b) Auto- and cross- correlation
curves calculated from the data belonging to a). c) Emission spectra ac-
quired in blood plasma with (blue, red curve) and without (black curve)
UCNPs. The blue curve was acquired with a 458 nm long pass filter, 458 nm
excitation wavelength and an excitation intensity of about 6.7 kWcm@2. The
red and black curves were acquired with 977 nm excitation wavelength and
an excitation intensity of about 1.8 MWcm@2. All spectra were recorded with
an exposure time of 100 s.
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cidence) and a short pass filter (500SP) in the thulium channel
transmitting only the spectral ranges shown in Figure S8. The sig-
nals were then detected by avalanche photodiodes (PerkinElmer
CD3226) connected to a single photon counting module (Becker &
Hickl SPC-830). The higher quantum yield of Er3+ doped UCNPs in
comparison to Tm3+ doped UCNPs was taken into account by a
0.7 neutral density filter in front of the Er3+ detecting avalanche
photodiode.[6] Recording of spectra was achieved by sending the
fluorescence signal to a liquid nitrogen cooled spectrograph
(Princeton Instruments SPEC-10:100B/LN eXcelon CCD camera, SP
2356 spectrometer, 300 groovesmm@1). Data was analyzed with
self-written Matlab algorithms.
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